HIV infection and stroke: current perspectives and future directions

Laura A Benjamin, Alan Bryer, Hedley C A Emsley, Saye Khoo, Tom Solomon, Myles D Connor

Research output: Contribution to journalArticlepeer-review

Abstract

HIV infection can result in stroke via several mechanisms, including opportunistic infection, vasculopathy, cardioembolism, and coagulopathy. However, the occurrence of stroke and HIV infection might often be coincidental. HIV-associated vasculopathy describes various cerebrovascular changes, including stenosis and aneurysm formation, vasculitis, and accelerated atherosclerosis, and might be caused directly or indirectly by HIV infection, although the mechanisms are controversial. HIV and associated infections contribute to chronic inflammation. Combination antiretroviral therapies (cART) are clearly beneficial, but can be atherogenic and could increase stroke risk. cART can prolong life, increasing the size of the ageing population at risk of stroke. Stroke management and prevention should include identification and treatment of the specific cause of stroke and stroke risk factors, and judicious adjustment of the cART regimen. Epidemiological, clinical, biological, and autopsy studies of risk, the pathogenesis of HIV-associated vasculopathy (particularly of arterial endothelial damage), the long-term effects of cART, and ideal stroke treatment in patients with HIV are needed, as are antiretrovirals that are without vascular risk.
Original languageEnglish
Pages (from-to)878-90
Number of pages13
JournalLancet Neurology
Volume11
Issue number10
DOIs
Publication statusPublished - Oct 2012

Keywords

  • Antiretroviral Therapy, Highly Active
  • HIV Infections
  • Humans
  • Stroke

Fingerprint

Dive into the research topics of 'HIV infection and stroke: current perspectives and future directions'. Together they form a unique fingerprint.

Cite this